Growth Metrics

Vycor Medical (VYCO) Cash from Investing Activities Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Vycor Medical - - 375,153.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -1,044.71%
Dec 31, 2024 102.88%
Sep 30, 2024 -25.02%
Mar 31, 2024 129.86%
Dec 31, 2023 -1,933.54%
Sep 30, 2023 -4,291.67%
Dec 31, 2022 2.22%
Sep 30, 2022 101.49%
Dec 31, 2021 116.41%
Sep 30, 2021 -3,275.92%
Jun 30, 2021 -80.74%
Mar 31, 2021 47.71%
Dec 31, 2020 93.88%
Sep 30, 2020 98.24%
Jun 30, 2020 -147.36%
Mar 31, 2020 -623.65%
Dec 31, 2019 -353.59%
Sep 30, 2019 -65.64%
Jun 30, 2019 94.95%
Mar 31, 2019 52.19%
Dec 31, 2018 69.83%
Sep 30, 2018 90.92%
Jun 30, 2018 -120.64%
Mar 31, 2018 81.45%
Dec 31, 2017 21.42%
Sep 30, 2017 -800.19%
Jun 30, 2017 -445.31%
Mar 31, 2017 -315.39%
Dec 31, 2016 82.09%
Sep 30, 2016 77.28%
Jun 30, 2016 82.26%
Mar 31, 2016 78.20%
Sep 30, 2015 40.71%
Jun 30, 2015 58.38%
Mar 31, 2015 -93.91%
Sep 30, 2014 42.12%
Jun 30, 2014 47.29%
Mar 31, 2014 70.81%
Dec 31, 2013 -348.37%
Sep 30, 2013 -140.77%
Jun 30, 2013 -167.31%
Mar 31, 2013 11.91%
Dec 31, 2012 116.11%
Sep 30, 2012 -529.23%
Jun 30, 2012 56.02%
Mar 31, 2012 -1,648.10%
Dec 31, 2011 89.91%
Sep 30, 2011 -10.23%